- Home
- IGC vs OPTH Comparison
IGC vs OPTH Comparison
Compare IGC & OPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IGC | OPTH |
|---|---|---|
| Founded | 2005 | 2020 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.0M | 28.9M |
| IPO Year | 2005 | 2024 |
Fundamental Metrics
Financial Performance| Metric | IGC | OPTH |
|---|---|---|
| Price | $0.25 | $3.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 637.8K | 32.6K |
| Earning Date | 11-05-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,271,000.00 | N/A |
| Revenue This Year | N/A | $56.17 |
| Revenue Next Year | N/A | $82.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.24 | $3.04 |
| 52 Week High | $0.45 | $5.45 |
Technical Indicators
Market Signals| Indicator | IGC | OPTH |
|---|---|---|
| Relative Strength Index (RSI) | 33.22 | 27.29 |
| Support Level | $0.24 | N/A |
| Resistance Level | $0.30 | $5.21 |
| Average True Range (ATR) | 0.01 | 0.31 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 0.67 | 18.32 |
Price Performance
Historical ComparisonAbout IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About OPTH Optimi Health Corp. Common Shares
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.